This report provides comprehensive information on the therapeutic development for Cerebral Infarction (Brain Infarction), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Cerebral Infarction (Brain Infarction) and special features on late-stage and discontinued projects. http://www.researchmoz.us/cerebral-infarction-brain-infarction-pipeline-review-h1-2015-report.html

1. Cerebral Infarction (Brain Infarction) - Pipeline Review, H1 2015
Global Markets Directs, Cerebral Infarction (Brain Infarction) Pipeline Review, H1 2015, provides an overview of the Cerebral Infarction (Brain Infarction)s
therapeutic pipeline.
This report provides comprehensive information on the therapeutic development for Cerebral Infarction (Brain Infarction), complete with comparative analysis at
various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates,
and featured news and press releases. It also reviews key players involved in the therapeutic development for Cerebral Infarction (Brain Infarction) and special
features on late-stage and discontinued projects.
Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built
using data and information sourced from Global Markets Directs proprietary databases, Company/University websites, SEC filings, investor presentations and
featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Directs team. Drug
profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the
latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that
the most recent developments are captured on a real time basis.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by
identifying new targets and MOAs to produce first-in-class and best-in-class products.
Scope
The report provides a snapshot of the global therapeutic landscape of Cerebral Infarction (Brain Infarction) The report reviews key pipeline products under drug
profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities The report reviews
key players involved in the therapeutics development for Cerebral Infarction (Brain Infarction) and enlists all their major and minor projects The report
summarizes all the dormant and discontinued pipeline projects A review of the Cerebral Infarction (Brain Infarction) products under development by companies
and universities/research institutes based on information derived from company and industry-specific sources Pipeline products coverage based on various stages
of development ranging from pre-registration till discovery and undisclosed stages A detailed assessment of monotherapy and combination therapy pipeline
projects Coverage of the Cerebral Infarction (Brain Infarction) pipeline on the basis of target, MoA, route of administration and molecule type Latest news and
deals relating related to pipeline products
Reasons to buy
Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies Identify emerging players
with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage Develop strategic initiatives by understanding the
focus areas of leading companies Identify and understand important and diverse types of therapeutics under development for Cerebral Infarction (Brain
Infarction) Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline Devise corrective measures for pipeline projects
by understanding Cerebral Infarction (Brain Infarction) pipeline depth and focus of Indication therapeutics Develop and design in-licensing and out-licensing
strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope Modify the therapeutic
portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline
table Of Contents
table Of Contents 2
list Of Tables 4
list Of Figures 4
introduction 5
global Markets Direct Report Coverage 5
cerebral Infarction (brain Infarction) Overview 6
therapeutics Development 7
pipeline Products For Cerebral Infarction (brain Infarction) - Overview 7
pipeline Products For Cerebral Infarction (brain Infarction) - Comparative Analysis 8
cerebral Infarction (brain Infarction) - Therapeutics Under Development By Companies 9
cerebral Infarction (brain Infarction) - Therapeutics Under Investigation By Universities/institutes 10
cerebral Infarction (brain Infarction) - Pipeline Products Glance 11
clinical Stage Products 11
early Stage Products 12
cerebral Infarction (brain Infarction) - Products Under Development By Companies 13
cerebral Infarction (brain Infarction) - Products Under Investigation By Universities/institutes 14
cerebral Infarction (brain Infarction) - Companies Involved In Therapeutics Development 15
aprogen, Inc. 15
johnson & Johnson 16
shin Nippon Biomedical Laboratories, Ltd. 17
sihuan Pharmaceutical Holdings Group Ltd. 18
cerebral Infarction (brain Infarction) - Therapeutics Assessment 19
assessment By Monotherapy Products 19
assessment By Target 20
assessment By Mechanism Of Action 22
assessment By Route Of Administration 24
assessment By Molecule Type 26
Cerebral Infarction (Brain Infarction) - Pipeline Review, H1 2015

2. drug Profiles 28
ap-102 - Drug Profile 28
product Description 28
mechanism Of Action 28
r&d Progress 28
cinepazide Mesylate - Drug Profile 29
product Description 29
mechanism Of Action 29
r&d Progress 29
cnto-0007 - Drug Profile 30
product Description 30
mechanism Of Action 30
r&d Progress 30
epoetin Alfa - Drug Profile 31
product Description 31
mechanism Of Action 31
r&d Progress 31
monoclonal Antibody To Inhibit Hmgb1 For Brain Infarction - Drug Profile 32
product Description 32
mechanism Of Action 32
r&d Progress 32
peptide For Cerebral Infarction - Drug Profile 33
product Description 33
mechanism Of Action 33
r&d Progress 33
cerebral Infarction (brain Infarction) - Dormant Projects 34
cerebral Infarction (brain Infarction) - Discontinued Products 35
appendix 36
methodology 36
coverage 36
secondary Research 36
primary Research 36
expert Panel Validation 36
contact Us 36
disclaimer 37
ResearchMoz(http://www.researchmoz.us/) is the one stop online destination to find and buy market research reports & Industry Analysis. We fulfill all your
research needs spanning across industry verticals with our huge collection of market research reports. We provide our services to all sizes of organizations and
across all industry verticals and markets. Our Research Coordinators have in-depth knowledge of reports as well as publishers and will assist you in making an
informed decision by giving you unbiased and deep insights on which reports will satisfy your needs at the best price.
Contact:
Sales Team,
90 State Street,
Suite 700,
Albany NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free 866-997-4948
Email: sales@researchmoz.us
Website: http://www.researchmoz.us/
Cerebral Infarction (Brain Infarction) - Pipeline Review, H1 2015